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been widely used to reduce pain and inflammation which target key eicosanoid biosynthesis enzymes. 
Conserved from vertebrates to insects, the use of these eicosanoid pathway inhibitors offer opportunities 
to evaluate the roles of eicosanoids in less-characterized insect systems. In this study, we examine the 
potential roles of eicosanoids on malaria parasite survival in the mosquito Anopheles gambiae. Using 
Plasmodium oocyst numbers to evaluate parasite infection, general or specific inhibitors of eicosanoid 
biosynthesis pathways were evaluated. Following the administration of dexamethasone and 
indomethacin, respective inhibitors of phospholipid A2 (PLA2) and cyclooxygenase (COX), oocyst 
numbers were unaffected. However, inhibition of lipoxygenase (LOX) activity through the use of esculetin 
significantly increased oocyst survival. In contrast, 
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hydroxylase (EH), decreased oocyst numbers. These experiments were further validated through RNAi 
experiments to silence candidate genes homologous to EH in An. gambiae to confirm their contributions 
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Abstract: Eicosanoids are bioactive signaling lipids derived from the oxidation of fatty acids
that act as important regulators of immune homeostasis and inflammation. As a result, effective
anti-inflammatory drugs have been widely used to reduce pain and inflammation which target key
eicosanoid biosynthesis enzymes. Conserved from vertebrates to insects, the use of these eicosanoid
pathway inhibitors offer opportunities to evaluate the roles of eicosanoids in less-characterized insect
systems. In this study, we examine the potential roles of eicosanoids on malaria parasite survival in
the mosquito Anopheles gambiae. Using Plasmodium oocyst numbers to evaluate parasite infection,
general or specific inhibitors of eicosanoid biosynthesis pathways were evaluated. Following the
administration of dexamethasone and indomethacin, respective inhibitors of phospholipid A2 (PLA2)
and cyclooxygenase (COX), oocyst numbers were unaffected. However, inhibition of lipoxygenase
(LOX) activity through the use of esculetin significantly increased oocyst survival. In contrast,
12-[[(tricyclo[3.3.1.13,7]dec-1-ylamino)carbonyl]amino]-dodecanoic acid (AUDA), an inhibitor of
epoxide hydroxylase (EH), decreased oocyst numbers. These experiments were further validated
through RNAi experiments to silence candidate genes homologous to EH inAn. gambiae to confirm their
contributions to Plasmodium development. Similar to the results of AUDA treatment, the silencing of
EH significantly reduced oocyst numbers. These results imply that specific eicosanoids in An. gambiae
can have either agonist or antagonistic roles on malaria parasite survival in the mosquito host.
Keywords: eicosanoid signaling; mosquito; innate immunity; Plasmodium
1. Introduction
Mosquitoes are able to transmit numerous pathogens that cause high human morbidity and
mortality [1,2], most notably malaria, which causes over 200 million cases and 435,000 deaths every
year [3]. Caused by parasite of the genus Plasmodium, malaria is solely transmitted by anopheline
mosquitoes [2,4]. Without a reliable vaccine, treatment has thus far relied on the administration of
anti-malarial drugs, insecticides to reduce mosquito populations, and the use of long-lasting insecticidal
nets (LLINs) to create a physical barrier for transmission. However, emerging drug and insecticide
resistance has complicated current approaches of malaria control [2,5]. Therefore, understanding the
mechanisms that influence malaria parasite survival in the mosquito host is critical for new strategies
to control disease transmission.
Plasmodium parasites undergo severe bottlenecks in the mosquito which can be attributed to the
innate immune response that limits parasite survival [4,6]. This includes multiple mechanisms of
parasite killing [7–13] which involve the complex interplay between the mosquito midgut [14,15],
immune cells known as hemocytes [12,13,16], and humoral components of the hemolymph [7–9].
However, our understanding of the mosquito immune responses that determine vectorial capacity
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remain limited. One aspect of invertebrate immunity that has thus far received little attention is the role
of eicosanoids. These lipid-derived signaling molecules play critical roles in mediating inflammatory
processes in vertebrates [17,18], yet have only recently been examined in insects through studies of
immunity, renal physiology and reproduction [19–25].
Much of this work has been aided by commercially available eicosanoids and anti-inflammatory
drugs which inhibit enzymes required for eicosanoid biosynthesis [26], enabling studies of eicosanoid
function in insects [27–29]. Previous studies have demonstrated that eicosanoids have integral
roles in immune function, mediating phagocytosis, encapsulation, and melanization responses to
invading pathogens [28–32]. Yet, only recently has eicosanoid function begun to be addressed in
the mosquito Anopheles gambiae, where prostaglandin and lipoxin synthesis has been implicated in
anti-Plasmodium immunity and immune priming [23,25,33]. However, the study of eicosanoids in
mosquito immunity has been impaired by the lack of characterization of key oxidative enzymes
required for the conversion of arachidonic acid (AA) to prostaglandins (PGs), leukotrienes (LTs),
lipoxins (LXs) and dihydroxyeicosatrienoic acids (DHETs) derivatives.
Therefore, this study aims to address potential roles of eicosanoids in Plasmodium survival by
the administration of anti-inflammatory drugs targeting each of the major eicosanoid biosynthesis
pathways. Results from these inhibition experiments demonstrate that specific eicosanoids, and the
downstream effects of their activation, can behave as agonists or antagonists of malaria parasite
survival in the mosquito host. Together, these results argue that eicosanoids are important mediators
of mosquito physiology, and capable of influencing vectorial capacity in An. gambiae.
2. Materials and Methods
2.1. Mosquito Rearing
Anopheles gambiae mosquitoes (Keele strain) were reared at 27 ◦C and 80% relative humidity, with
a 14/10 hour day/night cycle. Larvae were fed on fish flakes (Tetramin, Tetra), and adult mosquitoes
were maintained on 10% sucrose solution.
2.2. Eicosanoid Inhibitors
Dexamethasone ((11β,16α)-9-Fluoro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione)
a phospholipase A2 inhibitor, indomethacin (1-(4-Chlorobenzoyl)-5-methoxy-2-methyl-3-indoleacetic
acid) a cyclooxygenase (COX) inhibitor, esculetin (6,7-Dihydroxycoumarin) a lipoxygenase (LOX)
inhibitor, and AUDA (12-[[(tricyclo[3.3.1.13,7] dec-1-ylamino) carbonyl]amino]-dodecanoic acid) an
epoxide hydrolase inhibitor, were purchased from Sigma-Aldrich. The chemicals were dissolved in
100% ethanol and diluted in 1 × PBS (phosphate buffered saline, pH 7.4) to prepare 10 µg/µL working
solution (23 mM of dexamethasone, 28 mM of indomethacin, 110 mM of esculetin and 12 mM of AUDA
in 1× PBS) similar to previous experiments [34]. Before initial use, inhibitor stocks were heated at
75 ◦C for 5 min to ensure that samples were completely dissolved. Sixty-nine nanoliters (nL) of each
inhibitor or 1× PBS: 5% ethanol control was injected intra-thoracically into naïve female mosquitoes
(3- to 5-day old) and maintained at 19 ◦C prior to subsequent challenge experiments.
2.3. Plasmodium berghei Infections
Female Swiss Webster mice were infected with a mCherry strain of Plasmodium berghei as described
previously [12,13]. For inhibitor experiments, mosquitoes were challenged with an infected mouse
24 h post-injection of either 1× PBS: 5% ethanol (control) or each of the respective eicosanoid inhibitors.
To evaluate the effects of gene-silencing on malaria parasite infection, mosquitoes were challenged with
a P. berghei-infected mouse four days post-injection of dsRNA. Infected mosquitoes were maintained at
19 ◦C until mosquitoes were dissected in 1× PBS seven or eight days post-infection to determine oocyst
numbers from individual mosquito midguts by fluorescence microscopy using a Nikon Eclipse 50i
(Nikon, Tokyo, Japan).
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2.4. Gene-Silencing Experiments
RNAi experiments were performed as previously described [12,13]. Briefly, T7 primers were
designed using the E-RNAi web application (http://www.dkfz.de/signaling/e-rnai3/idseq.php) to
specifically target genes of interest. These are listed in Table S1. cDNA prepared from whole
mosquitoes collected 24 h post-P. berghei infection was used as a template for dsRNA synthesis. PCR
amplicons were gel purified using the Gel DNA Recovery kit (Zymo Research, Orange, CA, USA)
and dsRNA was prepared using the MEGAscript RNAi kit (Life Technologies, NewYork, NY, USA)
according to the manufacturer’s instructions. dsRNA was resuspended in nuclease free water to a
final concentration of 3 µg/µL. Three to four day old mosquitoes were cold anesthetized and injected
intrathoracically with 69 nL (~200 ng) of dsRNA per mosquito using a Nanoject III injection system
(Drummond Scientific).
The effects of gene-silencing were evaluated four days post-injection of dsRNA in whole mosquito
samples (~15 mosquitoes per treatment). Total RNA was isolated using TRIzol (Thermo Fisher Scientific,
Waltham, MA, USA) and then treated with DNase I to remove gDNA contamination according to
the manufacture’s protocol (New England Biolabs, Ipswich, MA, USA). Total RNA (2 µg) was used
for cDNA synthesis using the RevertAid First Strand cDNA Synthesis kit (Thermo Fisher Scientific),
with resulting cDNA (1:5 dilution) used as a template for amplification with 500 nM of gene-specific
primers. Ribosomal protein S7 transcript levels were used as an internal reference as previously [11–13].
qRT-PCR was performed using PowerUp™SYBR®Green Master Mix (Thermo Fisher Scientific) with
the following cycling conditions: 95 ◦C for 10 min, 40 cycles with 95 ◦C for 15 s and 65 ◦C for 60 s.
A comparative CT (2−∆∆Ct) method was employed to determine relative transcript abundance for each
transcript [35].
2.5. Gene Expression Analysis
To determine whether silencing epoxide hydrolase was linked to the regulation of anti-microbial
peptide (AMPs) expression, relative AMP transcripts were examined using cDNA samples and
qRT-PCR experiments as described above. A list of primers used for gene expression analyses are
listed in Table S1.
3. Results
Previous work has suggested that eicosanoids contribute to the production of anti-microbial peptides,
immune priming, and anti-Plasmodium immunity in Anopheles [23,25,33]. However, the characterization
of the key oxidative enzymes converting arachidonic acid into specific eicosanoids has been limited in
mosquitoes [25,36]. To overcome this hurdle, we examined the potential role of eicosanoids onPlasmodium
infection using known eicosanoid inhibitors in An. gambiae. Prior to taking an infected blood meal,
mosquitoes were primed by the injection of specific inhibitors to interrupt the conversion of arachidonic
acid (AA) to prostaglandins (PGs), leukotrienes (LTs), lipoxins (LXs), or dihydroxyeicosatrienoic acid
(DHETs) derivatives (Figure 1A) to determine their respective influence on malaria parasite survival.
When PLA2 was targeted by dexamethasone treatment (Figure 1B) or when cyclooxygenase (COX)
activity was impaired by indomethacin (Figure 1C), Plasmodium oocyst numbers were unchanged when
compared to control mosquitoes (Figure 1B,C). However, treatment with esculetin or AUDA significantly
influenced parasite survival with agonistic or antagonistic effect. Esculetin treatment significantly
increased oocyst numbers (Figure 1D), while AUDA treatment decreased Plasmodium survival (Figure 1E).
Together, these results suggest that leukotrienes/lipoxins and DHETs influence mosquito immunity
and/or physiology to mediate vectorial capacity.
Insects 2019, 10, 307 4 of 9
Insects 2019, 10, x FOR PEER REVIEW 4 of 9 
 
Figure 1. Effect of eicosanoid inhibitors on Plasmodium oocyst survival. Biosynthesis pathways of 
eicosanoids as described in mammalian systems are summarized in (A). Arachidonic acid (AA) is 
derived from membrane phospholipids by hydrolysis of phospholipase A2 (PLA2) activity. The AA 
is further metabolized into various eicosanoids, such as prostaglandins (PGs), leukotrienes (LTs), 
lipoxins (LXs) and dihydroxyeicosatrienoic acids (DHETs) through the activity of specific enzymes, 
cyclooxygenase (COX), lipoxygenase (LOX), cytochrome P450 (CYP), and epoxide hydrolase (EH), 
respectively. The influence of specific eicosanoid inhibitors on P. berghei survival was addressed in 
mosquitoes injected with each respective inhibitor by examining oocyst numbers at 8 days post-
infection (B–E). Compared to an ethanol (EtOH) control, oocyst survival was examined for the PLA2 
inhibitor, dexamethasone (DEX) (B), a COX inhibitor, indomethacin (INDO) (C), a LOX inhibitor, 
esculetin (ES) (D), and an epoxide hydrolase inhibitor, AUDA (E). Data were analyzed by Mann-
Whitney U using GraphPad Prism 6.0. Bar graphs represent mean ± SEM of three independent 
experiments. Asterisks denote significance (* p < 0.05); ns, not significant. 
Since previous work has argued for the role of lipoxins in immune priming and innate immune 
function in An. gambiae [23], and genes orthologous to mammalian lipoxygenase (LOX) have not been 
found, we focused our attention on the DHET pathway. Using orthologous genes for epoxide 
hydrolase [36–38], the enzyme responsible for the production of DHETs (Figure 2A), we identified 
two potential candidates in the An. gambiae genome: cytoplasmic epoxide hydrolase 2 (cEH2; 
AGAP003542) and epoxide hydrolase (EH; AGAP011972), of which EH function has previously been 
confirmed for the generation of epoxy fatty acids [36]. Thus, RNAi experiments targeting each gene 
were performed to determine their roles in Plasmodium survival. Both cEH and EH were effectively 
silenced following dsRNA injection as compared to GFP controls (Figures 2B and 2C), yet only EH-
silencing significantly influenced oocyst numbers (Figures 2C), resulting in a similar phenotype to 
AUDA treatment (Figure 1E). This provides further support for the influence of DHETs on malaria 
parasite survival. 
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derived from membrane phospholipids by hydrolysis of phospholipase A2 (PLA2) activity. The AA
is further metabolized into various eicosanoids, such as prostaglandins (PGs), leukotrienes (LTs),
lipoxins (LXs) and dihydroxyeicosatrienoic acids (DHETs) through the activity of specific enzymes,
cyclooxygenase (COX), lipoxygenase (LOX), cytochrome P450 (CYP), and epoxide hydrolase (EH),
respectively. The influence of specific eicosanoid inhibitors on P. berghei survival was addressed in
mosquitoes injected with each respective inhibitor by examining oocyst numbers at 8 days post-infection
(B–E). Compared to an ethanol (EtOH) control, oocyst survival was examined for the PLA2 inhibitor,
dexamethasone DEX) (B), a COX inhibitor, indomethacin (IN O) (C), a LOX inhibitor, esculeti (ES)
(D), and an epoxide hydrolase inhibitor, AUDA (E). Data w r analyzed by Mann-Whitn y U using
GraphPad Prism 6.0. Bar graphs represent mean ± SEM of three independent experiments. Asterisks
denote significance (* p < 0.05); ns, not significant.
Since previous work has argued for the role of lipoxins in immune priming and innate immune
function in An. gambiae [23], and genes orthologous to mammalian lipoxygenase (LOX) have not
been found, we focused our attention on the DHET pathway. Using orthologous genes for epoxide
hydrolase [36–38], the enzyme responsible for the production of DHETs (Figure 2A), we identified
two potential candidates in the An. gambiae genome: cytoplasmic epoxide hydrolase 2 (cEH2;
AGAP003542) and epoxide hydrolase (EH; AGAP011972), of whic E function has previously
been confirmed f r the generation of epoxy f tty acids [36]. Thus, RNAi experiments targeting
each gene were performed to determine their roles in Plasmodium s rvival. Both cEH and EH were
effectively silenced following dsRNA injection as compared to GFP controls (Figure 2B,C), yet only
EH-silencing significantly influenced oocyst numbers (Figure 2C), resulting in a similar phenotype to
AUDA treatment (Figure 1E). This provides further support for the influence of DHETs on malaria
parasite survival.
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by qRT-PCR and the effects of the gene knockdown on oocyst survival were evaluated for either 
cytoplasmic epoxide hydrolase (cEH) (B) or EH (C) and compared to green fluorescent protein (GFP) 
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by qRT-PCR and the effects of the gene knockdown on oocyst survival ere eval ate for eit er
cytoplasmic epoxide hydrolase (cEH) (B) or E ( ) and co pared to green fluorescent protein ( FP)
controls. qRT-PCR data were analyzed by an unpaired t-test. Bar graphs represent mean ± SEM of three
independent experiments. Data from oocyst assessment were pooled from three or ore independent
experiments with statistical analysis determined by a Mann–Whitney test using GraphPad Prism
6.0. Asterisks denote significance (** p < 0.01, *** p < 0.001, **** p < 0.0001); ns, not significant. CYP,
cytochrome P450.
To further examine the influence of DHETs in An. ga biae, i f
anti-microbial peptides (AMPs). Previous stu ies le
quinquefasciatus increased AMP production [38], therefore e a t t
production could similarly account for the reduction in Plasmodium survival following AUDA-treatment
(Figure 1E) that w re reconstituted by EH-silencing (F gure 2C). To approach this question, orthol gs
of the AMPs previously examined in response to the i gestion of AUDA in Culex were evaluated;
including cecropin 1 (CEC1, AGAP000693), cecropin 3 (CEC3, AGAP000694), cecropin 4 (CEC ,
AGAP006722), defensin 1 (DEF1, AGAP011294) and gambicin (GAM, AGAP008645). However, when
AMP expression was examined after EH-silencing, no discernable differences were detected (Figure 3).
This suggests that the negative influence of AUDA-treatment and EH-silencing on malaria parasite
survival is independent of AMP expression.
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Figure 3. Epoxide hydrolase (EH)-silencing does not influence AMP expression. The effects of EH-silencing
on anti-microbial peptide (AMP) expression were evaluated by qRT-PCR. Relative gene expression was
compared between EH-silenced whole mosquitoes and that of green fluorescent protein (GFP) controls.
Data were analyzed using an unpaired t-test to determine differences in relative gene expression of each
respective AMP gene between GFP and EH dsRNA treatments. Bars represent mean ± SEM of three
independent experiments. CEC1 (cecropin 1, AGAP000693), CEC3 (cecropin 3, AGAP000694), CEC4
(cecropin 4, AGAP006722), DEF1 (defensin 1, AGAP011294) and GAM (gambicin, AGAP008645).
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4. Discussion
Eicosanoids have been extensively studied in mammalian systems for their roles in immune
regulation and inflammation, by modulating cytokine release, cell differentiation, cell migration,
antigen presentation, and apoptosis [18,39,40]. Similar conserved responses have also been described
in insects, with eicosanoids mediating cellular immune function through phagocytosis, encapsulation,
or melanization responses [28–32]. Recent studies have also implicated eicosanoid function in mosquito
immune priming to subsequent pathogen challenge [23,25]. However, the significance of eicosanoids
in mosquito physiology and immune function has only recently been addressed [23,25,33,36–38,41],
leaving several fundamental questions of eicosanoid function in the mosquito host unanswered.
This includes the potential role of eicosanoids in mediating the vectorial capacity of Anopheles to
malaria parasites [23,25,41], which, due to the complexity of eicosanoid pathways and the limited
knowledge of the enzymes responsible for its biosynthesis, has not been fully addressed. Using a
pharmaceutical approach with known eicosanoid inhibitors, we examined the potential roles of each
major eicosanoid biosynthesis pathway on Plasmodium oocyst numbers.
The initiation of eicosanoid biosynthesis is elicited by phospholipase A2 (PLA2) activity, which
cleaves fatty acid and subsequently releases arachidonic acid (AA) [42]. In insects, the important roles
of PLA2 in hemocyte migration [25,43] and antimicrobial peptide (AMP) expression [33,44,45] have
been described following the injection of the PLA2 inhibitors, dexamethasone and benzylideneacetone.
However, when mosquitoes were treated with dexamethasone prior to challenging with P. berghei,
malaria parasite numbers were not affected. Given the reciprocal outcomes of esculetin and AUDA
treatment which respectively increase and decrease parasite survival, we argue that the presumed
downstream influence on each of these respective pathways likely counter the singular effects of
each pathway.
Similar to dexamethasone, our experiments with indomethacin do not influence Plasmodium
oocyst numbers, suggesting that prostaglandins do not contribute to parasite survival. However,
this contrasts a recent report which states that mosquito anti-Plasmodium immunity can be primed by
the injection of several prostaglandin derivatives including PGE1, PGE2 and PGF2α [25]. One possible
explanation is that indomethacin, a COX inhibitor, may not inhibit the heme peroxidases HPX7 and
HPX8 which were recently implicated in PGE2 synthesis [25]. Alternatively, since indomethacin can
impair vertebrate peroxidase activity [46], and the injection of indomethacin can influence Plasmodium
sporozoite salivary gland numbers [41], it is plausible that indomethacin can similarly inhibit mosquito
HPX activity. Further experiments are therefore required to delineate the potential inhibitory effects of
indomethacin on prostaglandin signaling in mosquitoes.
Our experiments with esculetin, a specific inhibitor of LOX, suggest that an unidentified enzyme(s)
analogous to lipoxygenases could be present in An. gambiae. Esculetin treatment prior to P. berghei
infection resulted in a significant increase in oocyst numbers, suggesting that the inhibition of
leukotriene and/or lipoxin synthesis makes mosquitoes more susceptible to infection. These findings
are in agreement with previous work demonstrating that lipoxin-A4 and -B4 mediate immune
priming [23].
In addition, our experiments demonstrate that AUDA treatment can significantly reduce parasite
survival. Previous studies in An. gambiae have suggested that AUDA inhibits the enzymatic activity of
an epoxide hydrolase which metabolizes epoxide fatty acids [36]. In our experiments the silencing
of EH, but not cEH, recapitulate the effects of AUDA on Plasmodium numbers. This suggests that
impairing the production of downstream DHETs influences mosquito immunity or physiology, making
mosquitoes more refractory to parasite infection. Based on the previously described increase in AMP
expression following AUDA ingestion [38], we similarly examined AMP expression in EH-silenced
mosquitoes to see if this could account for the increased anti-Plasmodium effects associated with this
phenotype. However, there was no change in AMP expression, leaving the molecular mechanisms
underlying EH enzymatic activity and its influence on parasite survival unresolved in this study.
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At present, it is unclear if these effects are immune-related or due to physiological changes which limit
resources required for Plasmodium development in the mosquito host.
5. Conclusions
Through these studies, we have addressed the role of eicosanoid biosynthesis on malaria
parasite survival through the use of pharmaceutical inhibitors, which offer new potential areas
of investigation into the lipid signaling mechanisms that determine mosquito vector competence.
However, the molecular contributions of eicosanoids on Plasmodium development still remain elusive,
primarily due to the incomplete understanding of the core enzymes involved in eicosanoid biosynthesis
and the resulting downstream effects of lipid signaling on mosquito innate immunity and physiology.
As a result, we believe that this study is an important initial step in our understanding of eicosanoid
function in mosquitoes.
Supplementary Materials: The following are available online at http://www.mdpi.com/2075-4450/10/10/307/s1,
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